We turn care
into evidence.
Celéri Health is a healthcare evidence infrastructure company — building the platforms, datasets, and partner networks that turn real-world patient outcomes into defensible, publication-ready, commercially actionable evidence. Founded in the belief that the healthcare industry proves too little, too slowly, and at too great a cost.
Build the evidence infrastructure that ensures the right therapy reaches the right patient — faster, at lower cost, and with proof that works.
Founded on the belief that people living with chronic pain deserve better evidence, faster — and that Real World Outcomes® are how we get there.
The principles behind the platform.
Celéri was built around a set of convictions about what's broken in healthcare evidence — and what it takes to fix it.
Evidence should be generated in the real world, not just the lab.
Randomized controlled trials answer narrow questions under controlled conditions. Real-world evidence answers the questions that actually drive clinical decisions, payer coverage, and market adoption — at scale, in actual care settings.
Commercial intelligence and regulatory evidence should share the same infrastructure.
The most expensive data in medtech is data that has to be gathered twice. Celéri builds platforms where the commercial team and medical affairs draw from the same governed dataset — one source of truth, two functions, no rebuild.
The patient's experience is the most important data point.
Validated patient-reported outcomes — captured consistently, longitudinally, and in the context of real care — are the foundation of every evidence program Celéri builds. PROs are not a nice-to-have. They are the story.
Speed is a clinical and commercial obligation.
Patients are waiting. Markets are moving. A platform that takes 18 months to deploy and costs eight figures to run is not the answer for most organizations. Celéri delivers evidence infrastructure in 8 weeks — at 85% lower cost than traditional study models.
Pain is undertreated, under-measured, and underserved.
Chronic pain affects more people than cancer, diabetes, and heart disease combined — yet it remains one of the least well-understood conditions in medicine. Celéri was founded to change that, starting with the data infrastructure that makes understanding possible.
The right partner network matters as much as the right technology.
Evidence generation is not a technology problem alone. It requires clinical expertise, regulatory fluency, behavioral science, and communication strategy working together. Celéri brings all of those — through its own team and through a curated network of best-in-class partners.
The people behind the platform.
A team with deep roots in healthcare technology, clinical research, commercial strategy, and enterprise software — united by a shared conviction that pain data should drive better outcomes.
Sean leads Celéri's strategy and commercial direction, bringing operating and investment expertise to the company's growth as an evidence infrastructure platform. Under his leadership, Celéri has expanded from a point-of-care analytics tool into a full-stack evidence-as-a-service company serving medtech, pharma, and payers across pain and neuromodulation.
Cam drives Celéri's strategy, commercialization, partnerships, and client engagement — with a focus on translating the platform's evidence infrastructure into tangible outcomes for sponsors and physicians. With over 25 years in healthcare management, managed care, and clinical strategy, she brings a patient-first perspective to every commercial decision.
David has more than a decade of experience leading technology companies through scale — including roles as CTO at PulsePoint and BlueCava (acquired by WebMD and Qualia respectively), and Chief Architect at mOcean (acquired by Pubmatic). He began his career at Sun Microsystems and holds a CS Engineering degree from the University of Pennsylvania.
Chris leads client services and product delivery across Celéri's EaaS engagements and PainIntel platform. He holds a BS in Finance from the University of Delaware and an MBA from UNC Chapel Hill with a concentration in Entrepreneurship. Prior to Celéri, Chris held roles in capital markets at JP Morgan and in market entry strategy for digital health startups.
One company. Four connected products.
Every Celéri product connects to the others — from point-of-care data capture to large-scale real-world benchmarking to sponsored evidence programs.
Celéri EaaS™ Platform
End-to-end evidence infrastructure for medtech and pharma sponsors — Commercial Insights Registry™, Regulatory-Grade Evidence Cohort™, and Traditional Prospective Study on one governed platform.
PainIntel™
Point-of-care platform for interventional pain physicians — 30+ validated PRO instruments, 8 EHR integrations, automated patient outreach, and a real-time Pain Command Center.
PainRWD™ Science Cloud
260,000 de-identified patients — the world's first pain-centric real-world dataset, used for external control groups, HEOR modeling, benchmarking, and comparative effectiveness analysis.
Celéri Research Group
Best-in-class curated partner network — CRO, biostatistics, EDC, QMS, behavioral science, regulatory consulting, and reputation building — assembled around what each study actually needs.
Ready to build your evidence infrastructure?
Whether you're a medtech sponsor, a pain physician, a payer, or a researcher — we'd like to hear what you're trying to prove.
